**vo **rdisk type 2 diabetes combo drug tops Sa**fi?s Lantus -study

[ahlam1399]

**vo **rdisk type 2 diabetes combo drug tops Sa**fi?s Lantus -study
June 7 (Reuters) - **vo **rdisk's IDegLira combination drug for type 2 diabetes led to significant reductions in blood sugar, weight and rate of hypoglycemia compared with Sa**fi's top-selling Lantus insulin product, according to data from a late-stage trial presented at a medical meeting on Sunday.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47034605/sc/3/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=aBaBme9ueIQ:iOMPi1ug2po:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=aBaBme9ueIQ:iOMPi1ug2po:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=aBaBme9ueIQ:iOMPi1ug2po:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=aBaBme9ueIQ:iOMPi1ug2po:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=aBaBme9ueIQ:iOMPi1ug2po:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/aBaBme9ueIQ